Tenax Therapeutics (NASDAQ: TENX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.110 | -0.110 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Tenax Therapeutics (NASDAQ: TENX) through any online brokerage.
Other companies in Tenax Therapeutics’s space includes: PolarityTE (NASDAQ:PTE), Exicure (NASDAQ:XCUR), Benitec Biopharma (NASDAQ:BNTC), Addex Therapeutics (NASDAQ:ADXN) and Histogen (NASDAQ:HSTO).
The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by HC Wainwright & Co. on Tuesday, December 29, 2020. The analyst firm set a price target for 5.00 expecting TENX to rise to within 12 months (a possible 1471.34% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Tenax Therapeutics (NASDAQ: TENX) is $0.3182 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Tenax Therapeutics.
Tenax Therapeutics’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Tenax Therapeutics.
Tenax Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.